Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 16.29
(-0.12%)
CNY 16.29
(-0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 193.29 Million | 3.48 Billion | 528.69 Million | 1.58 Billion | 68.92 Million | 72.36 Million |
| Net Income | 1.35 Billion | 2.35 Billion | 1.34 Billion | 1.21 Billion | 603.04 Million | 592.95 Million |
| Depreciation & Amortization | 547.4 Million | 451.46 Million | 362.93 Million | 268.16 Million | 259.69 Million | 253.16 Million |
| Deferred income taxes | 104.48 Million | -158.7 Million | 20.13 Million | -67.66 Million | -8.86 Million | -23.8 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.86 Billion | 547.84 Million | -1.3 Billion | 24.78 Million | -856.49 Million | -760.39 Million |
| Other non-cash items | 3.03 Billion | 131.6 Million | 133.86 Million | 78.29 Million | 62.68 Million | -13.35 Million |
| Investing Cash Flow | -937.05 Million | -1.99 Billion | -506.75 Million | -1.04 Billion | 37.12 Million | 46.36 Million |
| Investments in PPE | -310.83 Million | -213.98 Million | -673.55 Million | -1.14 Billion | -454.42 Million | -187.22 Million |
| Acquisitions | -675.31 Million | 350.52 Thousand | 2.37 Million | 1.14 Billion | 7.12 Million | - |
| Investment purchases | -3.63 Billion | -3.46 Billion | -451.04 Million | -2.85 Billion | -2.11 Billion | -1.37 Billion |
| Sales/Maturities of investments | 3.68 Billion | 1.68 Billion | 616.64 Million | 2.95 Billion | 2.59 Billion | 1.59 Billion |
| Other Investing Activities | 87.9 Million | 0.93 | -1.17 Million | -1.14 Billion | 246.53 Thousand | 8.64 Million |
| Financing Cash Flow | -220.59 Million | -637 Million | -302.14 Million | -23.26 Million | -169.58 Million | -143.85 Million |
| Debt repayment | -549.7 Million | -2.2 Billion | -1.46 Billion | -269.98 Million | -50 Million | - |
| Dividends payments | -835.35 Million | -282.7 Million | -1.19 Billion | -238.67 Million | -119.77 Million | -120.63 Million |
| Common Stock Repurchased | - | - | - | - | -99.95 Million | -50 Million |
| Common Stock Issuance | - | - | - | - | 49.95 Million | - |
| Other Financing Activities | 69.58 Million | 1.84 Billion | 2.38 Billion | 490.81 Million | 50.2 Million | -23.22 Million |
| Accounts receivables | -700.49 Million | -831.65 Million | -1.28 Billion | -668.73 Million | -800.36 Million | -823.02 Million |
| Accounts payables | -722.76 Million | 1.88 Billion | 55.14 Million | 1.12 Billion | -6.41 Million | 131.21 Million |
| Inventory | -459.66 Million | -348.01 Million | -104.73 Million | -364.91 Million | -40.84 Million | -105.38 Million |
| Other working capital | 17.35 Million | -158.7 Million | 20.13 Million | -67.66 Million | -8.86 Million | -655 Million |
| Cash at beginning of period | 1.9 Billion | 953.48 Million | 1.23 Billion | 713.41 Million | 777.58 Million | 802.67 Million |
| Cash at end of period | 940.51 Million | 1.81 Billion | 953.48 Million | 1.23 Billion | 713.41 Million | 777.58 Million |
| Capital Expenditure | -310.83 Million | -213.98 Million | -673.55 Million | -1.14 Billion | -454.42 Million | -187.22 Million |
| Effect of forex changes on cash | 326.39 Thousand | 1.24 Million | -481.42 Thousand | -1.95 Million | -635.14 Thousand | 26.92 Thousand |
| Net cash flow / Change in cash | -963.76 Million | 857.18 Million | -280.69 Million | 520.76 Million | -64.17 Million | -25.09 Million |
| Free Cash Flow | -117.54 Million | 3.27 Billion | -144.86 Million | 441.39 Million | -385.5 Million | -114.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 24.31 Million | 226.52 Million | 303.92 Million | 1.35 Billion | -406.3 Million | 152.66 Million |
| Depreciation & Amortization | - | 149.55 Million | 149.55 Million | 547.4 Million | 145.56 Million | -255.05 Million |
| Deferred income taxes | - | - | - | 104.48 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -207.2 Million | - | -1.86 Billion | -1.14 Billion | 956.78 Million |
| Other non-cash items | 34.38 Million | 69.93 Million | -173.57 Million | 3.03 Billion | 579.29 Million | -1.39 Billion |
| Investing Cash Flow | -138.47 Million | 61.07 Million | 63.95 Million | -937.05 Million | 195.47 Million | 55 Million |
| Investments in PPE | -129.09 Million | -42.15 Million | -62.82 Million | -310.83 Million | -102.34 Million | -86.06 Million |
| Acquisitions | 16.45 Thousand | - | 1610.62 | -675.31 Million | -47.07 Million | -129.19 Million |
| Investment purchases | -149.4 Million | -422 Million | -1.34 Billion | -3.63 Billion | -351.32 Million | -560 Million |
| Sales/Maturities of investments | 140 Million | 525.22 Million | 1.46 Billion | 3.68 Billion | 696.22 Million | 829.91 Million |
| Other Investing Activities | - | 102.96 Million | 140.13 Million | 87.9 Million | 361.82 Million | 355.84 Thousand |
| Financing Cash Flow | -219.01 Million | -158.9 Million | 70.02 Million | -220.59 Million | -367.77 Million | -180.59 Million |
| Debt repayment | -8.66 Million | -140.3 Million | -1.33 Million | -549.7 Million | -200.3 Million | -200 Million |
| Dividends payments | - | -501.21 Million | -7.89 Million | -835.35 Million | -835.35 Million | -387.07 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -227.67 Million | 487.19 Million | 71.35 Million | 69.58 Million | 672.4 Million | 406.47 Million |
| Accounts receivables | - | -748.41 Million | - | -700.49 Million | -700.49 Million | 466.24 Million |
| Accounts payables | - | - | - | -722.76 Million | - | - |
| Inventory | - | 541.21 Million | - | -459.66 Million | -459.66 Million | 490.53 Million |
| Other working capital | - | - | - | 17.35 Million | 17.35 Million | - |
| Cash at beginning of period | 1.22 Billion | 1.18 Billion | 940.51 Million | 1.9 Billion | 1.07 Billion | 1.65 Billion |
| Cash at end of period | 907.3 Million | 1.22 Billion | 1.18 Billion | 940.51 Million | 940.51 Million | 991.6 Million |
| Capital Expenditure | -129.09 Million | -42.15 Million | -62.82 Million | -310.83 Million | -102.34 Million | -86.06 Million |
| Effect of forex changes on cash | - | 39.66 Thousand | 5380.45 | 326.39 Thousand | -95.89 Thousand | -119.13 Thousand |
| Net cash flow / Change in cash | -316.44 Million | 33.99 Million | 249.24 Million | -963.76 Million | -132.1 Million | -661.62 Million |
| Free Cash Flow | -70.38 Million | 104.75 Million | 67.53 Million | -117.54 Million | -74.92 Million | -621.98 Million |
300417
RIVN
DELTA
ORIENTALTL
HPOL-B
LAMM-B